Valeria Santini

52PUBLICATIONS
320CO-AUTHORS
Medical mycologyGene and molecular therapyRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|May 06, 2026
Understanding the Molecular Mechanisms Underlying Anemia in Myelodysplastic Syndromes: From Erythropoiesis to New Therapeutic Approaches.

|Apr 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

|Apr 07, 2026
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes.

Amer M Zeidan, Valeria Santini, María Díez-Campelo

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

Pageof 9

Frequent Collaborators

26 joint publications

Uwe Platzbecker

19 joint publications

Rami S Komrokji

15 joint publications

Matteo Giovanni Della Porta

15 joint publications

María Díez-Campelo